Patents by Inventor Johann Hiebl

Johann Hiebl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240116881
    Abstract: Processes for preparation of ipconazole, processes for preparation of a compound of formula (V) and processes for preparation of a compound of formula (VI), which is a key intermediate useful for preparation of ipconazole are disclosed.
    Type: Application
    Filed: September 13, 2023
    Publication date: April 11, 2024
    Inventors: Sebastian Ebner, Johann Hiebl, Michael König, Samuel Ruehs, Raffael Schuecker, Cameron Gibb
  • Patent number: 6884874
    Abstract: Processes for preparing N-methyl-L-alanine derivatives and novel intermediates of the process. The derivatives and intermediates are useful for preparing cell-binding agent/maytansinoid complexes.
    Type: Grant
    Filed: March 17, 2003
    Date of Patent: April 26, 2005
    Assignee: SmithKline Beecham Corporation
    Inventors: Ann M. Eldridge, Johann Hiebl
  • Publication number: 20040014980
    Abstract: Processes for preparing N-methyl-alanine derivatives and novel intermediates of the process. The derivatives and intermediates are useful for preparing cell-binding agent/maytansinoid complexes.
    Type: Application
    Filed: March 17, 2003
    Publication date: January 22, 2004
    Applicant: SmithKline Beecham plc
    Inventors: Ann M. Eldridge, Johann Hiebl
  • Patent number: 6570024
    Abstract: Processes for preparing N-methyl-L-alanine derivatives and novel intermediates of the process. The derivatives and intermediates are useful for preparing cell-binding agent/maytansinoid complexes.
    Type: Grant
    Filed: December 3, 2001
    Date of Patent: May 27, 2003
    Assignee: SmithKline Beecham Corporation
    Inventors: Ann M. Eldridge, Johann Hiebl
  • Patent number: 6496100
    Abstract: A system for preventing inadvertent operation of remote keyless entry commands for a vehicle remote keyless entry system having a user interface located on the head of the vehicle ignition key. Whenever the ignition key is about to or has been inserted into the vehicle ignition, the user may inadvertently depress one or more of the command buttons of the keyhead. This accidental depression may occur before or during inserting the key, or after the key has been inserted and the key is being turned to activate the ignition. The system of the present invention selectively inhibits the vehicle from acting upon the commands when it is believed any of these situations may be occurring.
    Type: Grant
    Filed: September 9, 1999
    Date of Patent: December 17, 2002
    Assignee: Siemens VDO Automotive Corporation
    Inventor: Johann Hiebl
  • Publication number: 20020156318
    Abstract: Processes for preparing N-methyl-L-alanine derivatives and novel intermediates of the process. The derivatives and intermediates are useful for preparing cell-binding agent/maytansinoid complexes.
    Type: Application
    Filed: December 3, 2001
    Publication date: October 24, 2002
    Inventors: Ann M. Eldridge, Johann Hiebl
  • Patent number: 6412223
    Abstract: A drive system includes a selector assembly that selectively operates both a window drive assembly and a lock module drive assembly. The selector assembly preferably includes a slidable shaft attached to first and second inputs. The shaft is mounted to slide in response to an actuator such as solenoid. When the first input is engaged with the output of a drive motor, the motor operates to lock and unlock the lock module drive assembly. When the second input is engaged with the output, the drive motor operates the window drive assembly to drive the window.
    Type: Grant
    Filed: September 29, 2000
    Date of Patent: July 2, 2002
    Assignee: Siemens Automotive Corporation
    Inventor: Johann Hiebl
  • Patent number: 6197793
    Abstract: Novel compounds of general formula (I) which have homoregulatory activities and can be used to stimulate haematopoiesis and for the treatment of viral, fungal and bacterial infectious diseases.
    Type: Grant
    Filed: December 4, 1998
    Date of Patent: March 6, 2001
    Assignees: SmithKline Beecham Corporation, Nycomed Austria GmbH
    Inventors: Pradip Kumar Bhatnagar, Michael Hartmann, Johann Hiebl, Peter Kremminger, Franz Rovenszky
  • Patent number: 6191146
    Abstract: The present invention relates to novel compounds which have hemoregulatory activities and can be used to stimulate hematopoiesis and for the treatment of viral, fungal and bacterial infectious diseases.
    Type: Grant
    Filed: April 1, 1999
    Date of Patent: February 20, 2001
    Assignees: SmithKline Beecham Corporation, Nycomed Austria GmbH
    Inventors: Pradip Kumar Bhatnagar, Dirk Andries Heerding, James Francis Callahan, Michael Hartmann, Johann Hiebl, Peter Kremminger, Franz Rovenszky
  • Patent number: 6177766
    Abstract: A control device for signal lights has a fully electronic flasher unit for intermittently activating the signal lights of the motor vehicle. A relay that is present in the vehicle in any case for other purposes and is likewise activated intermittently by the flasher unit is used to acoustically indicate to the driver when the signal lights are switched on. The fully electronic flasher unit is highly reliable. The relay provides the familiar acoustic feedback.
    Type: Grant
    Filed: September 10, 1999
    Date of Patent: January 23, 2001
    Assignee: Siemens Aktiengesellschaft
    Inventor: Johann Hiebl
  • Patent number: 6124298
    Abstract: The present invention relates to novel pyrazine compounds and their use in the regulation of haematopoiesis, in particular in the stimulation of haematopoiesis, and in the treatment of bacterial, viral and fungal diseases.
    Type: Grant
    Filed: August 20, 1999
    Date of Patent: September 26, 2000
    Assignee: Nycomed Imaging AS
    Inventors: Jessie Sandosham, Johann Hiebl, Hermann Kollmann, Alan Cuthbertson, Peter Fischer, Michael Hartmann, Peter Kremminger, Franz Rovenszky, Mette Husbyn
  • Patent number: 6114357
    Abstract: Novel compounds of general formula (1), which have hemoregulatory activities and can be used to stimulate haematopoiesis and for the treatment of viral, fungal and bacterial infectious diseases.
    Type: Grant
    Filed: February 9, 1999
    Date of Patent: September 5, 2000
    Assignees: SmithKline Beecham Corporation, Nycomed Austria GmbH
    Inventors: Pradip Kumar Bhatnagar, Dirk Andries Heerding, Michael Hartmann, Johann Hiebl, Peter Kremminger, Franz Rovenszky
  • Patent number: 6107309
    Abstract: The present invention relates to novel compounds which have hemoregulatory activities and can be used to stimulate hematopoiesis and for the treatment of viral, fungal and bacterial infectious diseases.
    Type: Grant
    Filed: December 4, 1998
    Date of Patent: August 22, 2000
    Assignees: SmithKline Beecham Corporation, Nycomed Austria GmbH
    Inventors: Pradip Kumar Bhatnagar, Dirk Andries Heerding, James Francis Callahan, Johann Hiebl, Michael Hartmann, Peter Kremminger, Franz Rovenszky
  • Patent number: 6077856
    Abstract: Novel compounds of the general formula (I) which have hemoregulatory activities and can be used to stimulate haematopoiesis and for the treatment of viral, fungal and bacterial infectious diseases ##STR1##
    Type: Grant
    Filed: December 14, 1998
    Date of Patent: June 20, 2000
    Assignees: SmithKline Beecham Corporation, Nycomed Austria GmbH
    Inventors: Pradip Kumar Bhatnagar, Dirk Andries Heerding, Michael Hartmann, Johann Hiebl, Peter Kremminger, Franz Rovenszky
  • Patent number: 6077855
    Abstract: Novel compounds of the general formula (I) which have hemoregulatory activities and can be used to stimulate haematopoiesis and for the treatment of viral, fungal and bacterial infectious diseases.
    Type: Grant
    Filed: December 4, 1998
    Date of Patent: June 20, 2000
    Assignees: SmithKline Beecham Corporation, Nycomed Austria GmbH
    Inventors: Pradip Kumar Bhatnagar, Michael Hartmann, Johann Hiebl, Peter Kremminger, Franz Rovenszky
  • Patent number: 6051584
    Abstract: Novel compounds of the general formula (I) which have hemoregulatory activities and can be used to stimulate haematopolesis and for the treatment of viral, fungal and bacterial infectious diseases ##STR1##
    Type: Grant
    Filed: November 23, 1998
    Date of Patent: April 18, 2000
    Assignees: SmithKline Beecham Corporation, Nycomed Austria GmbH
    Inventors: Pradip Kumar Bhatnagar, Michael Hartmann, Johann Hiebl, Peter Kremminger, Franz Rovenszky
  • Patent number: 6030989
    Abstract: Novel compounds of general formula (I) which have hemoregulatory activities and can be used to stimulate haematopoiesis and for the treatment of viral, fungal and bacterial infectious diseases.
    Type: Grant
    Filed: November 23, 1998
    Date of Patent: February 29, 2000
    Assignee: SmithKline Beecham Corporation
    Inventors: Pradip Kumar Bhatnagar, Michael Hartmann, Johann Hiebl, Peter Kremminger, Franz Rovenszky
  • Patent number: 5972926
    Abstract: The present invention relates to pyrazine fused to a cyclic peptide which is capable of regulating, in particular stimulating, haematopoiesis.
    Type: Grant
    Filed: June 5, 1998
    Date of Patent: October 26, 1999
    Assignee: Nycomed Imaging AS
    Inventors: Jessie Sandosham, Johann Hiebl, Hermann Kollmann, Alan Cuthbertson, Peter Fischer, Michael Hartmann, Peter Kremminger, Franz Rovenszky, Mette Husbyn
  • Patent number: 5643438
    Abstract: The invention relates to a new process for the preparation of substituted diaminodicarboxylic acid derivatives of the formula ##STR1## in a high yield by a modified Kolbe synthesis.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: July 1, 1997
    Assignee: Hafslund Nycomed Pharma Aktiengesellschaft
    Inventors: Johann Hiebl, Franz Rovenszky
  • Patent number: 5627302
    Abstract: The invention relates to novel asymmetrically substituted diaminodicarboxylic acid derivatives of the formula ##STR1##
    Type: Grant
    Filed: April 24, 1996
    Date of Patent: May 6, 1997
    Assignee: Hafslund Nycomed Pharma Aktiengesellschaft
    Inventors: Johann Hiebl, Franz Rovenszky